Kitano Marie, Aoki Shuichiro, Kitamoto Kohdai, Terao Ryo, Inoue Tatsuya, Obata Ryo, Azuma Keiko
Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Department of Ophthalmology, JR Tokyo General Hospital, 2-1-3 Yoyogi, Shibuya-ku, Tokyo, 151-8528, Japan.
Sci Rep. 2025 Sep 1;15(1):32250. doi: 10.1038/s41598-025-17499-9.
This single-center, retrospective study analyzed the development of macular neovascularization (MNV) in patients with chronic central serous chorioretinopathy (CSCR) during a treatment-free follow-up period and the factors associated with its development. In total, 236 patients (280 eyes, 149 males and 87 females, mean age 55.3 ± 13.9 years) with treatment-naïve CSCR with no MNV detected on multimodal imaging who were observed for > 6 months were assessed. The association between age, sex, the presence of MNV, central choroidal thickness (CCT), the presence of the double-layer sign (DLS), and the cumulative duration of the persistence of serous retinal detachment (SRD) was also analyzed to determine the visual outcome before the onset of MNV. Twenty-eight (10%) eyes developed MNV over a mean follow-up period of 48.3 ± 43.3 months. The persistence of SRD for ≥ 6 months (p = 0.003) and presence of DLS measuring ≥ 1000 μm in length and < 100 μm in height (p = 0.040) exhibited significant associations with the development of MNV. Furthermore, the persistence of SRD for ≥ 6 months showed a significant association with logMAR visual acuity loss of ≥ 0.3 (p = 0.0009). Thus, the persistence of SRD for ≥ 6 months and numerically defined DLS were identified as predictors for the development of MNV in patients with CSCR.
这项单中心回顾性研究分析了慢性中心性浆液性脉络膜视网膜病变(CSCR)患者在未治疗随访期间黄斑新生血管(MNV)的发生情况及其相关因素。总共评估了236例初治CSCR患者(280只眼,男性149例,女性87例,平均年龄55.3±13.9岁),这些患者在多模态成像中未检测到MNV,且观察时间>6个月。还分析了年龄、性别、MNV的存在、中心脉络膜厚度(CCT)、双层征(DLS)的存在以及浆液性视网膜脱离(SRD)持续的累积时间之间的关联,以确定MNV发病前的视力结果。在平均48.3±43.3个月的随访期内,28只(10%)眼发生了MNV。SRD持续≥6个月(p=0.003)以及长度≥1000μm且高度<100μm的DLS的存在(p=0.040)与MNV的发生显著相关。此外,SRD持续≥6个月与logMAR视力损失≥0.3显著相关(p=0.0009)。因此,SRD持续≥6个月和数值定义的DLS被确定为CSCR患者MNV发生的预测因素。